Global clinical trials support service market was valued at US$ 23.8 billion in 2022 and is projected to surpass US$ 44.5 billion by 2031 at a CAGR of 7.22% during the forecast period 2023–2031.
Global hand, foot, and mouth disease treatment market was valued at US$ 2,900.6 million in 2022 and is projected to generate a revenue of US$ 4,942.2 million by 2031 at a CAGR of 6.1% during the forecast period 2023–2031.
Global plant stem cells market was valued at US$ 371.4 million in 2022 and is projected to attain a valuation of US$ 801.9 million by 2031 at a CAGR of 8.93% during the forecast period 2023-2031.
United States liquid biopsy market was valued at US$ 3,405.8 million in 2022 and is projected to surpass market valuation of US$ 10,798 million by 2031 at a CAGR of 13.68% during the forecast period 2023–2031.
The global deuterated drugs market, valued at US$ 299.0 million in 2022, presents a robust growth pattern. With a projected valuation of US$ 780.7 million by 2031 at a CAGR of 11.25%, the market is driven by primary drugs including Austedo and Zepsun, used to treat Huntington's Disease (HD), Tardive Dyskinesia (TD), Cancer, and others.
Global Newcastle disease vaccine market was valued at US$ 300.97 million in 2022 and is projected to surpass valuation of US$ 441.29 million by 2031 at a CAGR of 3.9% during the forecast period 2023–2031.
Southeast Asia Olmesartan market was valued at US$ 322.8 million in 2022 and is projected to surpass valuation of US$ 491.79 million by 2031 at a CAGR of 4.3% during the forecast period 2023–2031.
Latin America insulin market was valued at US$ 2,855.1 million in 2022 and is projected to attain a valuation of US$ 3,857.50 million by 2031 at a CAGR of 3.4% during the forecast period 2023–2031.
The global hyaluronidase market exhibited a valuation of US$ 778.37 million in 2022, and it is projected to reach a market valuation of US$ 1,894.03 million by 2031, with a compound annual growth rate (CAGR) of 9.3% during the forecast period of 2023-2031.
Saudi Arabia generic pharmaceutical products market was valued at US$ 3,222.83 million in 2022 and is projected to attain a valuation of US$ 5,315.78 million by 2031 at a CAGR of 5.85% during the forecast period.
